Applied Cellular Physiology and Metabolic Engineering
A single nucleotide polymorphism in ycdC alters tRNA synthetase expression and results in hypersecretion in Escherichia coli
Article first published online: 21 MAY 2012
DOI: 10.1002/btpr.1550
Copyright © 2012 American Institute of Chemical Engineers (AIChE)
Additional Information
How to Cite
Gupta, P., Swanberg, J. C. and Lee, K. H. (2012), A single nucleotide polymorphism in ycdC alters tRNA synthetase expression and results in hypersecretion in Escherichia coli. Biotechnol Progress, 28: 646–653. doi: 10.1002/btpr.1550
Publication History
- Issue published online: 9 JUN 2012
- Article first published online: 21 MAY 2012
- Accepted manuscript online: 14 APR 2012 01:46AM EST
- Manuscript Revised: 6 APR 2012
- Manuscript Received: 27 DEC 2011
Funded by
- NYSTAR, NSF, and University of Delaware
Keywords:
- Escherichia coli;
- next generation sequencing;
- protein secretion
Abstract
The most important approach to the development of platform organisms for recombinant protein production relies on random mutagenesis and phenotypic selection. Complex phenotypes, including those associated with significantly elevated expression and secretion of heterologous proteins, are the result of multiple genomic mutations. Using next generation sequencing, a parent and derivative hypersecreter strain (B41) of Escherichia coli were sequenced with an average coverage of 52.8X and 55X, respectively. A new base-pair calling program, revealed a single nucleotide polymorphism in the B41 genome at position 1,074,787, resulting in translation termination near the N-terminus of a transcriptional regulator protein, RutR, coded by the ycdC gene. We verified the hypersecretion phenotype in a ycdC::Tn5 mutant and observed a 3.4-fold increase in active hemolysin secretion, consistent with the increase observed in B41 strain. mRNA expression profiling showed decreased expression of tRNA-synthetases and some amino acid transporters in the ycdC::Tn5 mutant. This study demonstrates the power of next generation sequencing to characterize mutants leading to successful metabolic engineering strategies for strain improvement. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012

1520-6033/asset/BTPR_left.gif?v=1&s=a5be2ff5a0fe6ccdaad74a6d128c142e5f71a8da)
1520-6033/asset/BTPR_right.gif?v=1&s=992d113a3e61fc9d3571812359165df86cf830e4)
